NMPA Approval

Ganciclovir and Sodium Chloride Injection

Approval Number

国药准字H20060432

Company宜昌三峡制药有限公司

Registration Date

July 8, 2020

Previous Approval Numbers

国药准字H20060432

Drug Information

Generic Name

更昔洛韦氯化钠注射液

Dosage Form

注射剂

Strength

100ml:更昔洛韦0.1g与氯化钠0.9g

Drug Type

化学药品

Registration Date

July 8, 2020

Company Information

Applicant Company

Company Name宜昌三峡制药有限公司

Manufacturing Company

Company Name宜昌三峡制药有限公司

Company Address

湖北省宜昌市东山经济开发区大连路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

更昔洛韦氯化钠注射液 - NMPA 批准文号 | MedPath